Table 5 |
||
|
Risk of Cancer in Various Sites Associated with ST Use and Smoking |
||
|
Cancer Site |
Risks from ST Use* |
Risks from Smoking** |
|
|
||
|
Pharynx |
No relationship |
RR= 5–11 |
|
Larynx |
No relationship |
13–15 |
|
Lung |
Inadequate |
13–23 |
|
Stomach |
Not persuasive |
1.4–2.0 |
|
Kidney |
No association |
1.3–3.7 |
|
Esophagus |
Not persuasive |
7–8 |
|
Pancreatic cancer |
Inconclusive |
2.3 |
|
Bladder cancer |
None |
2.2–3.3 |
|
|
||
|
* From [94]. ** Among current smokers (men and women), used by the CDC for national estimates of smoking-attributable mortality [96]. |
||
|
Rodu and Godshall Harm Reduction Journal 2006 3:37 doi:10.1186/1477-7517-3-37 |
||
